ReviewTargeted oncology2025

Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence.

José Ángel García-Saenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.